tripelennamine has been researched along with Conjugate Nystagmus in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yules, RB | 1 |
| Gault, FP | 1 |
| Uemura, T | 1 |
2 other studies available for tripelennamine and Conjugate Nystagmus
| Article | Year |
|---|---|
Effect of drugs on after-nystagmus induced by lateral vestibular nucleus stimulation.
Topics: Animals; Cats; Chlorpromazine; Cyclizine; Dimenhydrinate; Diphenhydramine; Electric Stimulation; Hyd | 1967 |
Efficacy of therapeutic drugs for vertigo.
Topics: Adult; Amobarbital; Dimenhydrinate; Electrooculography; Female; Histamine H1 Antagonists; Humans; Ma | 1969 |